Cited by 39Ethics in Clinical ResearchEthics and bioethics in healthcareMedical and Health Sciences Research

A trial of consent procedures for future research with clinically derived biological samples

Open access
Vermeulen, E, Schmidt, M K, Aaronson, N K, Kuenen, M, Baas-Vrancken Peeters, M-J, van der Poel, H, Horenblas, S, Boot, H +3 more·2009·British Journal of Cancer

Abstract

BACKGROUND: The aims of this study were to determine which consent procedure patients prefer for use of stored tissue for research purposes and what the effects of consent procedures on actual consenting behaviour are. METHODS: We offered 264 cancer patients three different consent procedures: 'one-time general consent' (asked written informed consent), 'opt-out plus' (had the opportunity to opt out by a form), or the standard hospital procedure (control group). The two intervention groups received a specific leaflet about research with residual tissue and verbal information. The control group only received a general hospital leaflet including opt-out information, which is the procedure currently in use. Subsequently, all patients received a questionnaire to examine their preferences for consent procedures. RESULTS: In all, 99% of patients consented to research with their residual tissue. In the 'one-time consent' group 85% sent back their consent form. Patients preferred 'opt-out plus' (43%) above 'one-time consent' (34%) or 'opt-out' (16%), whereas 8% indicated that they did not need to receive information about research with residual tissues or be given the opportunity to make a choice. CONCLUSIONS: The 'opt-out plus' procedure, which places fewer demands on administrative resources than 'one-time consent', can also address the information needs of patients.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/sj.bjc.6605339

Cites

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • In the Vermeulen et al. study at one cancer institute in the Netherlands, 82% of the onetime consent group and 65% of the opt-out plus group felt well informed, while 73% of the control group had not seen or did not remember the information about tissue research.

    “Among the respondents, 82% of those in the onetime consent group and 65% of those in the opt-out plus group felt well informed; by contrast, 73% of those in the control group had not seen or did not remember having read the information about tissue research.”

    From Lessons from HeLa Cells: The Ethics and Policy of Biospecimens (2016) · cites this paper as [144]

    Split into 2 atoms — 1 confirmed, 1 partially supported, 0 disputed, 0 misattributed, 0 unverifiable. Expand the claim to see per-atom verdicts.

    Experimental — accuracy not yet measured
  • In the Vermeulen et al. study, among all respondents, 43% preferred opt-out plus, 34% preferred onetime consent, 16% preferred standard opt-out, and 8% said no information was needed.

    “Among all respondents, 43% preferred opt-out plus, 34% preferred onetime consent, 16% preferred the standard opt-out procedure, and 8% said that no information at all was needed.”
  • In the Vermeulen et al. study, respondents who were younger, female, and more highly educated and considered themselves owners of their tissue were more likely to prefer onetime consent and opt-out plus over standard opt-out, and in all subgroups opt-out plus was preferred more often than other approaches.

    “Respondents who were younger, female, and more highly educated and considered themselves to be the owners of their tissue were more likely to prefer onetime consent and opt-out plus over standard opt-out. In all subgroups, opt-out plus was preferred more often than other approaches.”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

No references could be resolved yet.

Research works printed but not linked: 42

  1. Ashburn TT, Wilson SK, Eisenstein BI (2000) Human tissue research in the genomic era of medicine: balancing individual and societal interests. Arch Intern Med 160: 3377–3384 11112229
  2. Axler RE, Irvine R, Lipworth W, Morrell B, Kerridge IH (2008) Why might people donate tissue for cancer research? Insights from organ/tissue/blood donation and clinical research. Pathobiology 75: 323–329 19096227
  3. Bryant RJ, Harrison RF, Start RD, Chetwood AS, Chesshire AM, Reed MW, Cross SS (2008) Ownership and uses of human tissue: what are the opinions of surgical in-patients? J Clin Pathol 61: 322–326 18256118
  4. Caulfield T, Upshur RE, Daar A (2003) DNA databanks and consent: a suggested policy option involving an authorization model. BMC Med Ethics 4: E1 12513704 PMC140033
  5. Chen DT, Rosenstein DL, Muthappan P, Hilsenbeck SG, Miller FG, Emanuel EJ, Wendler D (2005) Research with stored biological samples: what do research participants want? Arch Intern Med 165: 652–655 15795341
  6. Coebergh JW, Van Veen EB, Vandenbroucke JP, van Diest P, Oosterhuis W (2006) One-time general consent for research on biological samples: opt out system for patients is optimal and endorsed in many countries. BMJ 332: 665 PMC1403227 16543343
  7. Dickenson D (2007) Property In The Body. Feminist Perspectives. Cambridge University Press: Cambridge
  8. Furness P (2003) Consent to using human tissue. BMJ 327: 759–760 14525848 PMC214050
  9. Furness PN, Nicholson ML (2004) Obtaining explicit consent for the use of archival tissue samples: practical issues. J Med Ethics 30: 561–564 15574445 PMC1733968
  10. Gevers JK (2004) Genetic databases and consent for use of medical records. Community Genet 7: 173–175 15692191
  11. Greely HT (1999) Breaking the stalemate: a prospective regulatory framework for unforseen research uses of human tissue samples and health information. Wake Forest Law Rev 34: 737–766 12664910
  12. Halamka JD (2006) Patients should have to opt out of national electronic care records: AGAINST. BMJ 333: 41–42 16821279
  13. Hamajima N, Tajima K, Oya H, Kato T, Okuma K, Kaneda H, Moritaka S, Kato T (1998) Patients’ views on residual blood use for research purposes. Jpn J Cancer Res 89: 341–345 9600130 PMC5921806
  14. Hamilton S, Hepper J, Hanby A, Hewison J (2007) Consent gained from patients after breast surgery for the use of surplus tissue in research: an exploration. J Med Ethics 33: 229–233 17400623 PMC2652782
  15. Hansson MG, Dillner J, Bartram CR, Carlson JA, Helgesson G (2006) Should donors be allowed to give broad consent to future biobank research? Lancet Oncol 7: 266–269 16510336
  16. Helft PR, Champion VL, Eckles R, Johnson CS, Meslin EM (2007) Cancer patients’ attitudes toward future research uses of stored human biological materials. J Emp Res Hum Res Ethics 2: 15–22 19385847
  17. Hewitt R, Watson PH, Dhir R, Aamodt R, Thomas G, Mercola D, Grizzle WE, Morente MM (2009) Timing of consent for the research use of surgically removed tissue: is Postoperative Consenting Acceptable? Cancer 115(1): 4–9 19090013
  18. Hoeyer K, Olofsson BO, Mjorndal T, Lynoe N (2004) Informed consent and biobanks: a population-based study of attitudes towards tissue donation for genetic research. Scand J Public Health 32: 224–229 15204184
  19. Jack AL, Womack C (2003) Why surgical patients do not donate tissue for commercial research: review of records. BMJ 327: 262 12896938 PMC167155
  20. Johnsson L, Hansson MG, Eriksson S, Helgesson G (2008a) Opt-out from biobanks better respects patients′ autonomy. BMJ 337: a1580 18784161
  21. Johnsson L, Hansson MG, Eriksson S, Helgesson G (2008b) Patients’ refusal to consent to storage and use of samples in Swedish biobanks: cross sectional study. BMJ 337: a345 18617496 PMC2656925
  22. Junghans C, Feder G, Hemingway H, Timmis A, Jones M (2005) Recruiting patients to medical research: double blind randomised trial of ‘opt-in’ vs ‘opt-out’ strategies. BMJ 331: 940–944 16157604 PMC1261191
  23. Kaphingst KA, Janoff JM, Harris LN, Emmons KM (2006) Views of female breast cancer patients who donated biologic samples regarding storage and use of samples for genetic research. Clin Genet 69: 393–398 16650074
  24. Kaufman D, Murphy J, Scott J, Hudson K (2008) Subjects matter: a survey of public opinions about a large genetic cohort study. Genet Med 10: 831–839 19011407
  25. Keulartz J, Schermer M, Korthals M, Swierstra T (2004) Ethics in technological culture: a programmatic proposal for a pragmatist approach. Sci Technol Human Values 29: 3–29 16013108
  26. Lauri G (2002) Genetic Privacy. A Challenge to Medico-Legal Norms. Cambridge University Press: Cambridge
  27. Malone T, Catalano PJ, O′Dwyer PJ, Giantonio B (2002) High rate of consent to bank biologic samples for future research: the Eastern Cooperative Oncology Group experience. J Natl Cancer Inst 94: 769–771 12011228
  28. Maschke KJ (2005) Navigating an ethical patchwork--human gene banks. Nat Biotechnol 23: 539–545 15877066
  29. Olsthoorn-Heim ETM, Gevers JKM (2004) Genetic research with stored human tissue; a coding procedure for optimal use of information and protection of privacy (comment). Article in Dutch. Genetisch onderzoek met opgeslagen lichaamsmateriaal: een coderingsprocedure met optimaal gebruik van informatie bij behoud van privacy (commentaar). Ned Tijdschr Geneesk 148: 1263 15301391
  30. Oosterhuis JW, Coebergh JW, Van Veen EB (2003) Tumour banks: well-guarded treasures in the interest of patients. Nat Rev Cancer 3: 73–77 12509769
  31. Pentz RD, Billot L, Wendler D (2006) Research on stored biological samples: views of African American and White American cancer patients. Am J Med Genet A 140: 733–739 16523508
  32. Start RD, Brown W, Bryant RJ, Reed MW, Cross SS, Kent G, Underwood JC (1996) Ownership and uses of human tissue: does the Nuffield bioethics report accord with opinion of surgical inpatients? BMJ 313: 1366–1368 8956702 PMC2352873
  33. Stegmayr B, Asplund K (2002) Informed consent for genetic research on blood stored for more than a decade: a population based study. BMJ 325: 634–635 12242175 PMC126305
  34. Treweek S, Doney A, Leiman D (2009) Public attitudes to the storage of blood left over from routine general practice tests and its use in research. J Health Serv Res Policy 14: 13–19 19103912
  35. van Diest PJ (2002) No consent should be needed for using leftover body material for scientific purposes. For. BMJ 325: 648–651 12242180
  36. Van Veen EB, Riegman PH, Dinjens WN, Lam KH, Oomen MH, Oosterhuis JW (2006) TuBaFrost 3: regulatory and ethical issues on the exchange of residual tissue for research across Europe. Eur J Cancer 42: 2914–2923 17029786
  37. Vermeulen E, Schmidt MK, Aaronson NK, Kuenen M, Van der Valk P, Sietses C, van den Tol P, van Leeuwen FE (2009a) Opt-out plus, the patients’ choice: preferences of cancer patients concerning information and consent regimen for future research with biological samples archived in the context of treatment. J Clin Pathol 62: 275–278 19017681
  38. Vermeulen E, Schmidt MK, Aaronson NK, Kuenen M, van Leeuwen FE (2009b) Obtaining ′fresh′ consent for genetic research with biological samples archived 10 years ago. Eur J Cancer 45: 1168–1174 19232486
  39. Watson N (2006) Patients should have to opt out of national electronic care records: FOR. BMJ 333: 39–40 16809714 PMC1494772
  40. Weir RF, Olick RS (2004) The Stored Tissue Issue. Oxford University Press: Oxford
  41. Wendler D (2006) One-time general consent for research on biological samples. BMJ 332: 544–547 16513715 PMC1388140
  42. Wheeler J, Agarwal M, Sugden J, Bladon M, Quirke P (2007) Experiences from the front line - routine consenting of surplus surgically removed tissue. Without investment by the NHS fully informed consent for all is not available. J Clin Pathol 60: 351–354 16950857 PMC2001129

Cited by

Sorted by citations

Authors
Vermeulen, E., Schmidt, M. K., Aaronson, N. K., Kuenen, M., Baas-Vrancken Peeters, M.-J., van der Poel, H., Horenblas, S., Boot, H., Verwaal, V. J., Cats, A., & van Leeuwen, F. E.
Affiliations
The Netherlands Cancer Institute (NL)
Venue
British Journal of Cancer
Published
2009-09-29
Volume
101
Issue
9
Pages
1505-1512
ISSN
  • 0007-0920 (ISSN-L)
  • 1532-1827
OpenAlex
W1999918196
Cited by
39
References
0
Citations by year
2026: 1 · 2025: 1 · 2021: 1 · 2020: 1 · 2019: 1 · 2018: 4 · 2017: 1 · 2016: 5 · 2015: 1 · 2014: 2 · 2013: 7 · 2012: 9
FWCI
4.71
Type
journal article
Language
en
Open access
Locations
  • British Journal of Cancer (publishedVersion, cc-by-nc-sa)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • Amsterdam UMC (VU Amsterdam) - Institutional Repository (publishedVersion)
  • Pure Amsterdam UMC (submittedVersion)
  • Data Archiving and Networked Services (DANS) (submittedVersion)
Funders
Cancer Genomics Centre
Topics
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Ethics in Clinical Research
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Ethics and bioethics in healthcare
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Medical and Health Sciences Research
Keywords
informed consent, presumed consent, residual tissue, cancer patients, patient preferences, patient information needs
MeSH terms
Female, Humans, Informed Consent, Male, Neoplasms, Surveys and Questionnaires, Tissue Banks, Patient Satisfaction, Biomedical Research

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review